Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Dyspepsia, Endoscopy upper gastrointestinal tract, Fibromyalgia, Gastritis
Clinical narrative: Heartburn and gastritis; Heartburn and gastritis; each covid vaccine+boosters caused a flare-up of my fibromyalgia; each covid vaccine+boosters caused a flare-up of my fibromyalgia; The initial case was missing the following minimum criteria: Unspecified AE. Upon receipt of follow-up information on (14Jun2022), this case now contains all required information to be considered valid.  This is a spontaneous report received from a contactable reporter (Consumer or other non HCP), Program ID: (159558). The reporter is the patient.  A 65-year-old female patient received BNT162b2 (BNT162B2), on 10Aug2021 at 16:00 as dose 1, single (Lot number: FA6780) at the age of 65 years intramuscular, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Fibromyalgia", start date: 1993 (ongoing), notes: Pertinent Details: take medications for sleep and pain; "Osteoporosis", start date: 2000 (ongoing); "Chronic fatigue syndrome", start date: 1993 (ongoing), notes: Pertinent Details: take medications for sleep and pain; "Tachycardia", start date: 1995 (ongoing); "Anxiety", start date: 1995 (ongoing); "sleep" (ongoing). Concomitant medication(s) included: AMITRIPTYLINE oral taken for fibromyalgia, start date: 1995 (ongoing); CLONAZEPAM oral taken for anxiety, sleep disorder, start date: 1995 (ongoing); METOPROLOL oral taken for tachycardia, start date: 1995 (ongoing); NABUMETONE; CELEBREX oral taken for fibromyalgia, start date: 2021 (ongoing). The following information was reported: DYSPEPSIA (non-serious), GASTRITIS (non-serious) all with onset 10Aug2021 at 16:20, outcome "not recovered" and all described as "Heartburn and gastritis"; FIBROMYALGIA (non-serious), CONDITION AGGRAVATED (non-serious) all with onset Aug2021, outcome "recovering" and all described as "each covid vaccine+boosters caused a flare-up of my fibromyalgia". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of fibromyalgia, condition aggravated. Therapeutic measures were taken as a result of dyspepsia, gastritis.  Additional information: Patient had some minor side effects after the first dose. Heartburn and gastritis started 20 mins after 1st booster of Covid vaccines. Treatment given were Pantoprazole and Famotidine. Each Covid vaccines and booster caused a flare-up of her fibromyalgia that started to resolve itself within one week after vaccine shot. She nowhad to take medication for heart burn and gastritis every day. Medication controled it but without medication, heart burn and gastritis came back. She was at higher risk for this due to long term use of anti-inflammatory drugs.  Follow-up (14Jun2022): This is a spontaneous follow-up report received from a contactable Consumer. Updated information included: RMH, lab data and dosage regimen updated. Concomitant medications product indication and dosage regimen updated (amitriptyline, clonazepam and metoprolol). Concomitant drug added (Celebrex). New event added (dyspepsia and gastritis).